Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Jabak Visited the Mais al-Jabal, Tebnine and Bint Jbeil Hospitals: I will Try to Support the Disadvantaged Areas with the Possible Means

 
Tebnine- Minister of Public Health Dr. Jamil Jabak visited this afternoon Tebnine Hospital as part of his tours of governmental hospitals in Marjayoun and Bint Jbeil districts. Jabak was received by MPs Ayoub Hmayyed, Hasan Fadlallah and Ali Bazzi, the chairman of the board of directors of the hospital Dr. Mohamad Hamadeh, the administrative body as well as physicians, Hezbollah official Cheikh Fouad Hanjoul and figures.
 
Jabak visited the hospital’s facilities and heard a briefing by Hamadeh of the equipment and the operations undertaken at the hospital and the large number of patients admitted to the hospital, coming from different regions and villages.

Jabak vowed to exert all possible efforts to provide assistance to the disadvantaged areas within the possible means in collaboration with the parliament and the Health committee.

“I promise to raise the financial ceiling of the governmental hospitals. Our top priority is to improve the quality of services provided by the governmental hospitals and rehabilitate them to admit patients all the month, in particular the uninsured ones,” Jabak added.
Jabak considered also that the salary scale law should apply to the employees and workers of the hospitals.
 
In a statement, Hmayed praised the effective role played by the Minister of Public Health.
 
Jabak and the MPs then visited Bint Jbeil Governmental hospital, where he was received by the chairman of the board of directors, Dr. Toufic Faraj and other figures.
 
“We are committed to provide a pioneering experience in the health care field. We deserve to have the best hospitals. Bint Jbeil Governmental hospital has the best equipment, so why should we transfer the patients to other hospitals or take them to hospitals in Sidon and Beirut?” Fadlallah stated.
 
Jabak visited later Mays al-Jabal Governmental Hospital with MPs Ali Fayyad and Kasem Hachem. He toured its facilities and departments and was informed on its needs in terms of the provision of medical services.
    5
ATC Name B/G Ingredients Dosage Form Price
L01XA03 OXALIPLATINE VIATRIS 5MG/ML G Oxaliplatin - 50mg 50mg Injectable powder for solution 4,428,565 L.L
L01XA03 OXALIPLATINO GP PHARM G Oxaliplatin - 50mg 50mg Injectable lyophilised powder for solution 2,956,454 L.L
L01XA03 OXALTIE G Oxaliplatin - 50mg 50mg Injectable lyophilised powder for solution 2,957,797 L.L
L01XA03 OXALTIE G Oxaliplatin - 50mg 50mg Injectable lyophilised powder 2,957,797 L.L
M04AA03 OXUBAT 120 G Febuxostat - 120mg 120mg Tablet, film coated 1,549,002 L.L
M04AA03 OXUBAT 80 G Febuxostat - 80mg 80mg Tablet, film coated 1,549,002 L.L
J01CA04 OSPAMOX G Amoxicillin (trihydrate) - 750mg 750mg Tablet, film coated 499,372 L.L
B05BC01 OSMITOL G Mannitol - 20g/100ml 20g/100ml Injectable solution 579,064 L.L
J01CA04 OSPAMOX G Amoxicillin (trihydrate) - 250mg/5ml 250mg/5ml Powder for suspension 223,078 L.L
M05BA04 OREK G Alendronate - 70mg 70mg Tablet, coated 2,404,838 L.L
J01CA04 OSPAMOX G Amoxicillin (trihydrate) - 1g 1,000mg Tablet, film coated 683,273 L.L
M05BA04 OSTEOMED G Alendronic acid (sodium alendronate) - 70mg 70mg Tablet, scored 950,929 L.L
H01AC01 OMNITROPE BioTech Somatropin recombinant - 5mg/1.5ml 5mg/1.5ml Injectable solution 26,295,375 L.L
H01AC01 OMNITROPE BioTech Somatropin recombinant - 10mg/1.5ml 10mg/1.5ml Injectable solution 45,388,478 L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 300mg/10ml 300mg/10ml Injectable concentrate for solution 547,517,314 L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 920mg/23ml 920mg/23ml Injectable solution 1,095,034,629 L.L
L01FD01 OGIVRI BioTech Trastuzumab - 440mg 440mg Injectable lyophilised powder 80,027,615 L.L
L01FF01 OPDIVO BioTech Nivolumab - 100mg/10ml 100mg/10ml Injectable solution L.L
L01FF01 OPDIVO BioTech Nivolumab - 100mg/10ml 100mg/10ml Injectable solution 117,224,380 L.L
L01FF01 OPDIVO BioTech Nivolumab - 40mg/4ml 40mg/4ml Injectable solution L.L
L01FF01 OPDIVO BioTech Nivolumab - 40mg/4ml 40mg/4ml Injectable solution 51,234,726 L.L
H05AA02 OSTEOFORTIL BioTech Teriparatide - 250mcg/ml 250mcg/ml Injectable solution 16,963,499 L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 300mg/10ml 300mg/10ml Injectable concentrate for solution L.L
J06BA02 OCTAGAM BioHuman Human normal immunoglobulin G - 50mg/ml 2.5g/50ml Injectable solution 19,540,934 L.L
J06BA02 OCTAGAM BioHuman Human normal immunoglobulin G - 50mg/ml 5g/100ml Injectable solution 37,672,334 L.L
J06BA02 OCTAGAM 10% BioHuman Human normal immunoglobulin G - 10% 5g/50ml Injectable solution 37,672,334 L.L
J06BA02 OCTAGAM BioHuman Human normal immunoglobulin G - 50mg/ml 10g/200ml Injectable solution 74,515,099 L.L
B02BD01 OCTAPLEX BioHuman Prothrombin complex, human (PPSB) - 500IU 500IU Injectable powder for solution+diluent 35,220,164 L.L
B02BD02 OCTANATE BioHuman Coagulation Factor VIII - 250IU 250IU Injectable lyophilised powder for solution+diluent 13,247,110 L.L
B02BD02 OCTANATE BioHuman Coagulation Factor VIII - 500IU 500IU Injectable lyophilised powder for solution+diluent 26,495,478 L.L
    5
Sitemap
© Copyrights reserved to Ministry of Public Health 2025